HIGHLIGHTS
- who: Wei Wang from the Ohio State University Hospital, United States have published the paper: Thrombomodulin activation driven by LXR agonist attenuates renal injury in diabetic nephropathy, in the Journal: (JOURNAL)
- what: The authors evaluated the serum levels of FXIII-A and TM, the expression of TM, LXR-u03b1 and FXIII-A in the renal tissue of patients with type 2 diabetic nephropathy. The authors aimed to reveal the interaction between FXIII-A and TM activation and their protective effects against renal injury in db/db mice after up-regulating/down-regulating TM expression. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.